While we’re on the topic of that $80 billion deal struck between Democratic leaders and the nation’s drug makers, it’s worth clarifying how it came to be. Many
“„Senate Finance Committee Chairman Max Baucus (D-Mont.) announced he secured an $80 billion commitment from the pharmaceutical industry to reduce Medicare prescription drug costs for seniors. The deal struck by Baucus and the nation’s pharmaceutical companies with the participation of the White House includes a provision to narrow the gap in coverage, often called the “doughnut hole,” with payments from the drug companies to cover up to 50 percent of the cost of brand name medicine in Medicare’s Part D prescription drug program.